project . 2015 - 2018 . Closed

HemAcure

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A

Open Access mandate for Publications European Commission

Funder: European CommissionProject code: 667421 Call for proposal: H2020-PHC-2015-two-stage
Funded under: H2020 | RIA Overall Budget: 5,564,400 EURFunder Contribution: 5,564,400 EUR
Status: Closed
Start Date
01 Nov 2015
End Date
31 Oct 2018
Detailed project information (CORDIS)

Open Access mandate
Research Data: No

Link this project to...
Research outcomes
Deposit your research

Share results

Select content type to share

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::dd7875b3563afabd34eb2cd6f4fb9d86&type=results"></script>');
-->
</script>

For further information contact us at helpdesk@openaire.eu

Download report
Select content type report to download

Summary
Publications
Research Data
Software
Other Research
Dmps

Description

The main objective of the HemAcure project is to develop and refine the tools and technologies for a novel ex vivo prepared cell based therapy to treat the bleeding disease haemophilia A (caused by genetic deficiency in clotting factor VIII (FVIII)) that should ultimately lead to improved quality of life of the patients. The concept is a further development of our approach, established during the FP7 ReLiver project led by Medicyte. From the very beginning, we balance two important goals, maximizing the product’s efficacy and safety profile on one side and minimizing production cost on the other by enhancing the product’s manufacturability. HemAcure relates to t...

Partners

Loughborough University, SERNOVA CORP., UNIPMN, ARTTIC, IMS EK, GRU, GABO:mi, KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVER

Summary

Description

Partners

Loughborough University, SERNOVA CORP., UNIPMN, ARTTIC, IMS EK, GRU, GABO:mi, KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVER

Any information missing or wrong?Report an Issue